 Matthew Jackman
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Gain | 15 | 2019 | 509 | 1.720 |
Why?
| | Energy Metabolism | 25 | 2024 | 873 | 1.490 |
Why?
| | Obesity | 23 | 2022 | 2879 | 1.380 |
Why?
| | Dietary Fats | 13 | 2018 | 301 | 1.370 |
Why?
| | Weight Loss | 11 | 2021 | 732 | 1.330 |
Why?
| | Caloric Restriction | 4 | 2019 | 111 | 0.880 |
Why?
| | Adipocytes | 5 | 2022 | 204 | 0.770 |
Why?
| | Adipose Tissue | 10 | 2022 | 590 | 0.700 |
Why?
| | Mitochondria, Muscle | 4 | 2019 | 111 | 0.630 |
Why?
| | Rats, Wistar | 12 | 2024 | 441 | 0.570 |
Why?
| | Energy Intake | 13 | 2020 | 461 | 0.560 |
Why?
| | Diet, High-Fat | 9 | 2018 | 239 | 0.510 |
Why?
| | Physical Conditioning, Animal | 5 | 2020 | 229 | 0.510 |
Why?
| | Diet, Fat-Restricted | 5 | 2013 | 80 | 0.490 |
Why?
| | Body Weight | 7 | 2024 | 939 | 0.490 |
Why?
| | Muscle, Skeletal | 13 | 2022 | 1613 | 0.470 |
Why?
| | Ovariectomy | 5 | 2024 | 135 | 0.380 |
Why?
| | Diet, Reducing | 1 | 2011 | 87 | 0.350 |
Why?
| | Lipid Metabolism | 7 | 2017 | 497 | 0.350 |
Why?
| | Fatty Liver | 5 | 2018 | 230 | 0.350 |
Why?
| | Rats | 19 | 2024 | 5482 | 0.350 |
Why?
| | Liver | 9 | 2024 | 1839 | 0.320 |
Why?
| | Lactation | 3 | 2018 | 169 | 0.320 |
Why?
| | Genes, Mitochondrial | 1 | 2008 | 13 | 0.290 |
Why?
| | NADH Dehydrogenase | 1 | 2008 | 18 | 0.290 |
Why?
| | Fatty Acids | 4 | 2021 | 426 | 0.280 |
Why?
| | Intra-Abdominal Fat | 1 | 2008 | 88 | 0.280 |
Why?
| | Triglycerides | 6 | 2015 | 527 | 0.270 |
Why?
| | Estradiol | 2 | 2024 | 494 | 0.260 |
Why?
| | Physical Exertion | 3 | 2011 | 205 | 0.260 |
Why?
| | Animals | 35 | 2024 | 35307 | 0.260 |
Why?
| | Ovary | 3 | 2024 | 207 | 0.240 |
Why?
| | Overweight | 2 | 2022 | 531 | 0.240 |
Why?
| | Menopause | 3 | 2019 | 297 | 0.240 |
Why?
| | Lipoprotein Lipase | 2 | 2021 | 59 | 0.240 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 639 | 0.230 |
Why?
| | Adaptation, Physiological | 4 | 2015 | 513 | 0.230 |
Why?
| | Oxidative Phosphorylation | 3 | 2016 | 187 | 0.230 |
Why?
| | Subcutaneous Fat | 2 | 2015 | 74 | 0.230 |
Why?
| | Milk | 3 | 2018 | 119 | 0.230 |
Why?
| | Body Composition | 5 | 2024 | 649 | 0.210 |
Why?
| | Fructokinases | 2 | 2013 | 31 | 0.200 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 235 | 0.200 |
Why?
| | Leptin | 2 | 2022 | 219 | 0.190 |
Why?
| | Oxidation-Reduction | 6 | 2011 | 1028 | 0.190 |
Why?
| | Oxygen Consumption | 4 | 2019 | 672 | 0.190 |
Why?
| | Exercise | 4 | 2018 | 1925 | 0.190 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 33 | 0.190 |
Why?
| | Mitochondria | 5 | 2022 | 877 | 0.180 |
Why?
| | Mentally Ill Persons | 1 | 2021 | 13 | 0.180 |
Why?
| | Homeostasis | 3 | 2015 | 605 | 0.170 |
Why?
| | Motor Activity | 2 | 2019 | 675 | 0.170 |
Why?
| | alpha-Linolenic Acid | 1 | 2000 | 8 | 0.170 |
Why?
| | Stearic Acids | 1 | 2000 | 15 | 0.170 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 574 | 0.170 |
Why?
| | Oleic Acid | 1 | 2000 | 39 | 0.170 |
Why?
| | Appetite | 1 | 2020 | 61 | 0.170 |
Why?
| | Muscle Fibers, Slow-Twitch | 2 | 2016 | 10 | 0.160 |
Why?
| | Muscle Fibers, Fast-Twitch | 2 | 2016 | 10 | 0.160 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 187 | 0.160 |
Why?
| | Fasting | 2 | 2000 | 267 | 0.160 |
Why?
| | Lipogenesis | 1 | 2019 | 59 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.160 |
Why?
| | Thermogenesis | 1 | 2019 | 44 | 0.150 |
Why?
| | Diet | 3 | 2018 | 1212 | 0.150 |
Why?
| | Physical Endurance | 2 | 2016 | 262 | 0.150 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 74 | 0.150 |
Why?
| | Global Health | 1 | 2021 | 327 | 0.150 |
Why?
| | Cold Temperature | 1 | 2019 | 154 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Cholesterol | 1 | 2019 | 412 | 0.140 |
Why?
| | Eating | 1 | 2020 | 368 | 0.140 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2017 | 47 | 0.140 |
Why?
| | Adipogenesis | 1 | 2017 | 50 | 0.140 |
Why?
| | Sphingolipids | 1 | 2018 | 71 | 0.140 |
Why?
| | Postprandial Period | 2 | 2015 | 104 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 4 | 2010 | 2396 | 0.140 |
Why?
| | Recurrence | 4 | 2019 | 1005 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 104 | 0.130 |
Why?
| | Catecholamines | 1 | 1996 | 96 | 0.130 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2017 | 138 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 169 | 0.130 |
Why?
| | Caffeine | 1 | 1996 | 62 | 0.130 |
Why?
| | Mental Health Services | 1 | 2021 | 404 | 0.130 |
Why?
| | Bone Density | 1 | 2019 | 462 | 0.120 |
Why?
| | Lipectomy | 1 | 2015 | 7 | 0.120 |
Why?
| | Male | 21 | 2021 | 63501 | 0.120 |
Why?
| | Insulin | 3 | 2022 | 2325 | 0.120 |
Why?
| | Carbon Radioisotopes | 3 | 2006 | 35 | 0.120 |
Why?
| | Thigh | 1 | 2015 | 53 | 0.120 |
Why?
| | Central Nervous System Stimulants | 1 | 1996 | 154 | 0.120 |
Why?
| | Female | 22 | 2024 | 68543 | 0.110 |
Why?
| | Hyperlipidemias | 1 | 2015 | 126 | 0.110 |
Why?
| | Breast Feeding | 1 | 2018 | 423 | 0.110 |
Why?
| | Time Factors | 4 | 2019 | 6543 | 0.110 |
Why?
| | Transcription Factors | 3 | 2019 | 1647 | 0.110 |
Why?
| | Glycogen | 2 | 2008 | 55 | 0.110 |
Why?
| | Mice | 11 | 2022 | 16915 | 0.100 |
Why?
| | Sucrose | 1 | 2013 | 99 | 0.100 |
Why?
| | Disease Models, Animal | 6 | 2019 | 4057 | 0.100 |
Why?
| | Physical Fitness | 1 | 2014 | 203 | 0.100 |
Why?
| | Hormones | 2 | 2010 | 140 | 0.100 |
Why?
| | Exercise Tolerance | 1 | 2014 | 273 | 0.100 |
Why?
| | Mothers | 2 | 2018 | 730 | 0.100 |
Why?
| | Insulin Resistance | 2 | 2018 | 1165 | 0.090 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2011 | 30 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 28 | 0.090 |
Why?
| | Glucose Transporter Type 1 | 1 | 2011 | 49 | 0.090 |
Why?
| | Blood Glucose | 2 | 2018 | 2097 | 0.090 |
Why?
| | Estrous Cycle | 1 | 2010 | 21 | 0.090 |
Why?
| | Models, Biological | 2 | 2016 | 1722 | 0.090 |
Why?
| | Metabolism | 1 | 2010 | 38 | 0.090 |
Why?
| | Citric Acid Cycle | 2 | 2003 | 54 | 0.090 |
Why?
| | Biopsy | 2 | 2018 | 1091 | 0.080 |
Why?
| | Membrane Proteins | 2 | 2013 | 1117 | 0.080 |
Why?
| | Neural Pathways | 1 | 2011 | 302 | 0.080 |
Why?
| | Dietary Carbohydrates | 2 | 2009 | 151 | 0.080 |
Why?
| | Sex Characteristics | 3 | 2018 | 736 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2017 | 2374 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 133 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 339 | 0.070 |
Why?
| | Adiponectin | 2 | 2022 | 235 | 0.070 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 20 | 0.070 |
Why?
| | Basal Metabolism | 1 | 2008 | 58 | 0.070 |
Why?
| | Adiposity | 4 | 2015 | 504 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 171 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 178 | 0.070 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 5439 | 0.070 |
Why?
| | Estrogens | 1 | 2009 | 346 | 0.070 |
Why?
| | Palmitates | 1 | 2006 | 17 | 0.070 |
Why?
| | Carbon Dioxide | 2 | 2006 | 259 | 0.060 |
Why?
| | Breeding | 1 | 2006 | 62 | 0.060 |
Why?
| | Pyruvic Acid | 2 | 2003 | 52 | 0.060 |
Why?
| | Humans | 13 | 2022 | 129248 | 0.060 |
Why?
| | Intestinal Absorption | 1 | 2006 | 99 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 636 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 46 | 0.060 |
Why?
| | Adult | 8 | 2022 | 35495 | 0.060 |
Why?
| | Enteral Nutrition | 1 | 2006 | 188 | 0.060 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 37 | 0.050 |
Why?
| | Rabbits | 2 | 1996 | 777 | 0.050 |
Why?
| | Phosphorylation | 1 | 2008 | 1710 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 261 | 0.050 |
Why?
| | Perilipin-2 | 2 | 2013 | 36 | 0.050 |
Why?
| | Pregnancy | 4 | 2018 | 6391 | 0.050 |
Why?
| | Animals, Newborn | 2 | 2017 | 834 | 0.050 |
Why?
| | Fructose | 2 | 2013 | 106 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 64 | 0.050 |
Why?
| | Indians, North American | 1 | 2008 | 600 | 0.050 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1085 | 0.050 |
Why?
| | Calorimetry, Indirect | 2 | 2011 | 81 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2703 | 0.040 |
Why?
| | Digestive System | 1 | 2000 | 29 | 0.040 |
Why?
| | Exercise Test | 2 | 2009 | 612 | 0.040 |
Why?
| | Betaine | 2 | 2013 | 75 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 622 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 28 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2022 | 381 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2019 | 51 | 0.040 |
Why?
| | Fever | 1 | 2000 | 298 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 428 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 286 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 195 | 0.040 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 40 | 0.040 |
Why?
| | Transcriptome | 1 | 2024 | 874 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 376 | 0.040 |
Why?
| | Phenotype | 1 | 2006 | 3074 | 0.040 |
Why?
| | Adenosine Triphosphate | 2 | 2016 | 478 | 0.040 |
Why?
| | Cell Size | 1 | 2017 | 87 | 0.040 |
Why?
| | Cohort Studies | 1 | 2008 | 5408 | 0.040 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 68 | 0.030 |
Why?
| | Nutritional Status | 1 | 2000 | 328 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2009 | 2140 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 219 | 0.030 |
Why?
| | Glucose Clamp Technique | 1 | 2018 | 194 | 0.030 |
Why?
| | Temperature | 1 | 2000 | 634 | 0.030 |
Why?
| | Running | 1 | 2019 | 223 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2011 | 10199 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 355 | 0.030 |
Why?
| | Phosphocreatine | 1 | 2016 | 43 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 183 | 0.030 |
Why?
| | Creatine Kinase | 1 | 2016 | 73 | 0.030 |
Why?
| | Physical Conditioning, Human | 1 | 2016 | 39 | 0.030 |
Why?
| | Electron Transport | 1 | 1996 | 112 | 0.030 |
Why?
| | Norepinephrine | 1 | 1996 | 210 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2013 | 2871 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2015 | 13 | 0.030 |
Why?
| | Ethanol | 1 | 2000 | 589 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1265 | 0.030 |
Why?
| | Lactic Acid | 1 | 1996 | 298 | 0.030 |
Why?
| | Double-Blind Method | 2 | 1996 | 1875 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.030 |
Why?
| | Middle Aged | 4 | 2018 | 31087 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 368 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 941 | 0.030 |
Why?
| | Circadian Rhythm | 2 | 2009 | 413 | 0.030 |
Why?
| | Choline | 1 | 1995 | 124 | 0.030 |
Why?
| | Bicycling | 1 | 1995 | 116 | 0.030 |
Why?
| | Body Temperature | 1 | 1994 | 212 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 41 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 98 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2014 | 120 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1994 | 541 | 0.030 |
Why?
| | Meals | 1 | 2014 | 119 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1204 | 0.030 |
Why?
| | Fatigue | 1 | 1995 | 316 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 191 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 610 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2014 | 332 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 1965 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1446 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 302 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 305 | 0.020 |
Why?
| | Methylnitrosourea | 1 | 2009 | 7 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1212 | 0.020 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.020 |
Why?
| | Thermodynamics | 2 | 2003 | 406 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 682 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 326 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 438 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2009 | 212 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1036 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1288 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2009 | 437 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1416 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1691 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5045 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4076 | 0.020 |
Why?
| | Glucose | 1 | 2011 | 1001 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 62 | 0.020 |
Why?
| | Rats, Zucker | 1 | 2005 | 30 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2779 | 0.020 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 52 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 151 | 0.010 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2005 | 97 | 0.010 |
Why?
| | Methionine | 1 | 2005 | 156 | 0.010 |
Why?
| | Malates | 1 | 2003 | 7 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3201 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 9745 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2015 | 2473 | 0.010 |
Why?
| | Glutathione | 1 | 2005 | 347 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2439 | 0.010 |
Why?
| | Glycolysis | 1 | 2005 | 311 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 537 | 0.010 |
Why?
| | Reperfusion Injury | 1 | 2005 | 272 | 0.010 |
Why?
| | Carbon | 1 | 2003 | 204 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2737 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2630 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2537 | 0.010 |
Why?
| | Pyruvate Carboxylase | 1 | 2000 | 2 | 0.010 |
Why?
| | Fluorescence Polarization | 1 | 2000 | 38 | 0.010 |
Why?
| | Radioisotope Dilution Technique | 1 | 2000 | 13 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2000 | 83 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1644 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 186 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 315 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 12388 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2000 | 763 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 1995 | 521 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 785 | 0.010 |
Why?
|
|
Jackman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|